Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/40699
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | DEFERM, Sebastien | - |
dc.contributor.author | BERTRAND, Philippe | - |
dc.contributor.author | DHONT, Sebastiaan | - |
dc.contributor.author | von Bardeleben, Ralph S. | - |
dc.contributor.author | VANDERVOORT, Pieter | - |
dc.date.accessioned | 2023-08-21T10:27:05Z | - |
dc.date.available | 2023-08-21T10:27:05Z | - |
dc.date.issued | 2023 | - |
dc.date.submitted | 2023-08-03T10:26:12Z | - |
dc.identifier.citation | Heart Failure Clinics, 19 (3) , p. 357 -377 | - |
dc.identifier.issn | 1551-7136 | - |
dc.identifier.uri | http://hdl.handle.net/1942/40699 | - |
dc.description.abstract | The aging population is rising at record pace worldwide. Along with it, a steep increase in the prevalence of atrial fibrillation and heart failure with preserved ejection fraction is to be expected. Similarly, both atrial functional mitral and tricuspid regurgitation (AFMR and AFTR) are increasingly observed in daily clinical practice. This article summarizes all current evidence regarding the epidemiology, prognosis, pathophysiology, and therapeutic options. Specific attention is addressed to discern AFMR and AFTR from their ventricular counterparts, given their different pathophysiology and therapeutic needs. | - |
dc.description.sponsorship | ERASMUS 1 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.subject.other | Atrial functional mitral regurgitation | - |
dc.subject.other | Atrial functional tricuspid regurgitation | - |
dc.subject.other | Atrial fibrillation | - |
dc.subject.other | Atrial myopathy | - |
dc.subject.other | Functional mitral regurgitation | - |
dc.subject.other | Heart failure with preserved ejection fraction | - |
dc.subject.other | Isolated tricuspid regurgitation | - |
dc.subject.other | Left atrium | - |
dc.title | Arrythmia-Mediated Valvular Heart Disease | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 377 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 357 | - |
dc.identifier.volume | 19 | - |
local.format.pages | 21 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Vandervoort, PM (corresponding author), Schiepse bos 6, B-3600 Genk, Belgium. | - |
dc.description.notes | pieter.vandervoort@zol.be | - |
local.publisher.place | STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1016/j.hfc.2023.02.008 | - |
dc.identifier.pmid | 37230650 | - |
dc.identifier.isi | 001016742700001 | - |
dc.contributor.orcid | von Bardeleben, Ralph Stephan/0000-0002-1356-0037 | - |
dc.identifier.eissn | - | |
local.provider.type | wosris | - |
local.description.affiliation | [Deferm, Sebastien; von Bardeleben, Ralph S.] Hasselt Univ, Agoralaan Bldg, B-3590 Diepenbeek, Belgium. | - |
local.description.affiliation | [Bertrand, Philippe B.; Dhont, Sebastiaan; Vandervoort, Pieter M.] Mainz Univ Hosp, Dept Cardiol, Langenbeckstr 1, Mainz, Germany. | - |
local.description.affiliation | [Vandervoort, Pieter M.] Hosp Oost Limburg Genk, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium. | - |
local.description.affiliation | [Vandervoort, Pieter M.] Schiepse bos 6, B-3600 Genk, Belgium. | - |
local.uhasselt.international | yes | - |
item.fulltext | No Fulltext | - |
item.fullcitation | DEFERM, Sebastien; BERTRAND, Philippe; DHONT, Sebastiaan; von Bardeleben, Ralph S. & VANDERVOORT, Pieter (2023) Arrythmia-Mediated Valvular Heart Disease. In: Heart Failure Clinics, 19 (3) , p. 357 -377. | - |
item.accessRights | Closed Access | - |
item.contributor | DEFERM, Sebastien | - |
item.contributor | BERTRAND, Philippe | - |
item.contributor | DHONT, Sebastiaan | - |
item.contributor | von Bardeleben, Ralph S. | - |
item.contributor | VANDERVOORT, Pieter | - |
crisitem.journal.issn | 1551-7136 | - |
Appears in Collections: | Research publications |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.